A novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging is a research paper published in Frontiers in Endocrinology (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK NIH HHS
Grant: P30 DK079626
National Institutes of Health
Grant: 1UC4DK098085-01
The Human Islet Distribution Coordinating Center (UC4)
National Institutes of Health
Grant: 1R01DK137506-01A1
TARGETING MASH WITH NOVEL SMALL MOLECULE TXNIP INHIBITOR
FWCI
4.12
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords